Clinical Drug Experience Knowledgebase

Communicable Diseases (Phase 4)

Coronary Disease (Phase 4)

Coronavirus Infections (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Emergencies (Phase 3)

Gram-Negative Bacterial Infections (Phase 3)

Heart Diseases (Phase 4)

Hidradenitis (Phase 2)

Hidradenitis Suppurativa (Phase 2)

Immune System Diseases (Phase 2)

Infections (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Macrophage Activation Syndrome (Phase 2)

Multiple Organ Failure (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Insufficiency (Phase 3)

Respiratory Tract Infections (Phase 2)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Sepsis (Phase 3)

Severe Acute Respiratory Syndrome (Phase 4)

Toxemia (Phase 2)

Virus Diseases (Phase 4)